ArticleJournal of clinical medicine2024

Integrated Analysis of Remdesivir and Paxlovid in COVID-19 Patients: A Personalized Approach to High-Risk Individuals for Severe Evolution.

Andreea Fitero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.